SPONSOR
Minghui Pharmaceutical (Hangzhou) Ltd
Total Trials
2
Recruiting
2
Phases
Phase 3, Phase 1, Phase 2
Minghui Pharmaceutical (Hangzhou) Ltd is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Thyroid Eye Disease (TED), Advanced Solid Cancer.
The trial portfolio spans Phase 3, Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Minghui Pharmaceutical (Hangzhou) Ltd
How many clinical trials has Minghui Pharmaceutical (Hangzhou) Ltd sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Minghui Pharmaceutical (Hangzhou) Ltd, of which 2 are actively recruiting participants. These trials cover conditions including Thyroid Eye Disease (TED), Advanced Solid Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Minghui Pharmaceutical (Hangzhou) Ltd research focus on?
Minghui Pharmaceutical (Hangzhou) Ltd clinical trials span Thyroid Eye Disease (TED), Advanced Solid Cancer. The research pipeline includes Phase 3, Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Minghui Pharmaceutical (Hangzhou) Ltd clinical trial?
To participate in a Minghui Pharmaceutical (Hangzhou) Ltd trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Minghui Pharmaceutical (Hangzhou) Ltd trials with current recruitment status updated daily.
Clinical Trials by Minghui Pharmaceutical (Hangzhou) Ltd
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology